<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>NAPVSIPQ (NAP), an 8 amino acid <z:chebi fb="7" ids="16670">peptide</z:chebi> derived from activity-dependent neuroprotective protein (ADNP), provides neuroprotection through interaction with microtubules </plain></SENT>
<SENT sid="1" pm="."><plain>Previous results have demonstrated NAP protection against oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation in hippocampal cells in culture </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, in vivo studies have shown that NAP reduces caspase 3 activation in rats subjected to permanent mid-cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (a rat model of <z:hpo ids='HP_0001297'>stroke</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>Oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) has been associated with microtubule breakdown and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release from mitochondria leading to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Here, NAP in concentrations ranging from 10(-14)M to 10(-8)M completely blocked <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release in cortical neurons subjected to oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, quantitative microscopy coupled to microtubule immunocytochemistry suggested that NAP prevented microtubule degradation under <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>As <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release is a known initiator of the apoptotic pathway, it is suggested that NAP inhibits the early events of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>